Instituto de Investigaciones Clínicas Mar del Plata ( Site 0303) — Mar del Plata, Buenos Aires

Public research footprint of Instituto de Investigaciones Clínicas Mar del Plata ( Site 0303), compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Atherosclerotic Cardiovascular Disease (ASCVD) · Breast Neoplasms · Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Recently updated registry entries

NCT06077760 — A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus… (Recruiting)
NCT07060807 — A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016) (Recruiting)
NCT03486873 — Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Instituto de Investigaciones Clínicas Mar del Plata ( Site 0303)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.